Search
for
Sort by
Research 871–900 of 1000+
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Progeria (Hutchinson-Gilford Syndrome): Literature Review and Clinical Case
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- INTERFERONS IN DERMATOLOGY
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Frontal fibrosing alopecia and lichen planopilaris: epidemiology, treatment, and remission rate (2014-2024)
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- ALOPESİ AREATA TEDAVİSİNDE POTANSİYEL BAZI TIBBİ BİTKİ TÜRLERİNİN İNCELENMESİ
- Brief Treatment Modalities of Alopecia Areata: Review Article
- Poster Abstracts
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study
- Cutaneous Reactions to Drugs
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- Deciphering the molecular drivers for cashmere/pashmina fiber production in goats: a comprehensive review
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Photobiomodulation for Skin Pigmentation Disorders: A Dual-Function Treatment
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- A Comprehensive Review on Alopecia: Mechanisms, Classification, and Therapeutic Strategies
- Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease.
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series